Cargando…
Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS
Mitral valve disease (MVD) is an important and most frequently acquired heart disease found in dogs. MVD is classified into different stages according to its severity. There is a challenge in differentiation between asymptomatic and symptomatic stages of the MVD. Moreover, pulmonary hypertension (PH...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360550/ https://www.ncbi.nlm.nih.gov/pubmed/34383793 http://dx.doi.org/10.1371/journal.pone.0255611 |
_version_ | 1783737766327091200 |
---|---|
author | Riengvirodkij, Nattapon Roytrakul, Sittiruk Jaresitthikunchai, Janthima Phaonakrop, Narumon Charoenlappanich, Sawanya Sakcamduang, Walasinee |
author_facet | Riengvirodkij, Nattapon Roytrakul, Sittiruk Jaresitthikunchai, Janthima Phaonakrop, Narumon Charoenlappanich, Sawanya Sakcamduang, Walasinee |
author_sort | Riengvirodkij, Nattapon |
collection | PubMed |
description | Mitral valve disease (MVD) is an important and most frequently acquired heart disease found in dogs. MVD is classified into different stages according to its severity. There is a challenge in differentiation between asymptomatic and symptomatic stages of the MVD. Moreover, pulmonary hypertension (PH) is a common complication in dogs affected by MVD. In clinical practice, there are also some limitations to identify PH. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a technique that can characterize specific patterns of peptide mass called peptide barcodes from various samples. Besides, in combination with liquid chromatography-tandem mass spectrometry (LC-MS/MS), potential peptide sequences associated with specific conditions could be identified. The present study aimed to use MALDI-TOF coupled with LC-MS/MS to characterize specific peptide barcodes and potential peptide candidates in serum samples from healthy dogs, dogs with MVD stage B (MVD B, asymptomatic stage), MVD stage C (MVD C, symptomatic stage), MVD stage B with PH (MVD B PH), and MVD stage C with PH (MVD C PH). Discrete clusters of the 5 sample groups were identified by 3D plot analysis. Peptide barcodes also revealed differences in peptide patterns among the 5 groups. Six amino acid sequences of peptide candidates at 1,225.60, 1,363.85, 1,688.71, 1789.52, 2020.21, and 2156.42 Da were identified as part of the proteins CLCN1, CLUL1, EDNRA, PTEN, SLC39A7, and CLN6, respectively. The network interactions between these discovered proteins and common cardiovascular drugs were also investigated. These results demonstrate that MALDI-TOF MS has promise as an optional technique for diagnosing dogs affected by asymptomatic and symptomatic stages of MVD with and without PH. Further studies are required to identify peptide barcodes in dogs with other diseases to create peptide barcode databases in veterinary medicine before using this method as a novel diagnostic tool in the future. |
format | Online Article Text |
id | pubmed-8360550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-83605502021-08-13 Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS Riengvirodkij, Nattapon Roytrakul, Sittiruk Jaresitthikunchai, Janthima Phaonakrop, Narumon Charoenlappanich, Sawanya Sakcamduang, Walasinee PLoS One Research Article Mitral valve disease (MVD) is an important and most frequently acquired heart disease found in dogs. MVD is classified into different stages according to its severity. There is a challenge in differentiation between asymptomatic and symptomatic stages of the MVD. Moreover, pulmonary hypertension (PH) is a common complication in dogs affected by MVD. In clinical practice, there are also some limitations to identify PH. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a technique that can characterize specific patterns of peptide mass called peptide barcodes from various samples. Besides, in combination with liquid chromatography-tandem mass spectrometry (LC-MS/MS), potential peptide sequences associated with specific conditions could be identified. The present study aimed to use MALDI-TOF coupled with LC-MS/MS to characterize specific peptide barcodes and potential peptide candidates in serum samples from healthy dogs, dogs with MVD stage B (MVD B, asymptomatic stage), MVD stage C (MVD C, symptomatic stage), MVD stage B with PH (MVD B PH), and MVD stage C with PH (MVD C PH). Discrete clusters of the 5 sample groups were identified by 3D plot analysis. Peptide barcodes also revealed differences in peptide patterns among the 5 groups. Six amino acid sequences of peptide candidates at 1,225.60, 1,363.85, 1,688.71, 1789.52, 2020.21, and 2156.42 Da were identified as part of the proteins CLCN1, CLUL1, EDNRA, PTEN, SLC39A7, and CLN6, respectively. The network interactions between these discovered proteins and common cardiovascular drugs were also investigated. These results demonstrate that MALDI-TOF MS has promise as an optional technique for diagnosing dogs affected by asymptomatic and symptomatic stages of MVD with and without PH. Further studies are required to identify peptide barcodes in dogs with other diseases to create peptide barcode databases in veterinary medicine before using this method as a novel diagnostic tool in the future. Public Library of Science 2021-08-12 /pmc/articles/PMC8360550/ /pubmed/34383793 http://dx.doi.org/10.1371/journal.pone.0255611 Text en © 2021 Riengvirodkij et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Riengvirodkij, Nattapon Roytrakul, Sittiruk Jaresitthikunchai, Janthima Phaonakrop, Narumon Charoenlappanich, Sawanya Sakcamduang, Walasinee Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS |
title | Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS |
title_full | Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS |
title_fullStr | Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS |
title_full_unstemmed | Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS |
title_short | Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS |
title_sort | peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using maldi-tof ms and lc-ms/ms |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360550/ https://www.ncbi.nlm.nih.gov/pubmed/34383793 http://dx.doi.org/10.1371/journal.pone.0255611 |
work_keys_str_mv | AT riengvirodkijnattapon peptidebarcodesindogsaffectedbymitralvalvediseasewithandwithoutpulmonaryhypertensionusingmalditofmsandlcmsms AT roytrakulsittiruk peptidebarcodesindogsaffectedbymitralvalvediseasewithandwithoutpulmonaryhypertensionusingmalditofmsandlcmsms AT jaresitthikunchaijanthima peptidebarcodesindogsaffectedbymitralvalvediseasewithandwithoutpulmonaryhypertensionusingmalditofmsandlcmsms AT phaonakropnarumon peptidebarcodesindogsaffectedbymitralvalvediseasewithandwithoutpulmonaryhypertensionusingmalditofmsandlcmsms AT charoenlappanichsawanya peptidebarcodesindogsaffectedbymitralvalvediseasewithandwithoutpulmonaryhypertensionusingmalditofmsandlcmsms AT sakcamduangwalasinee peptidebarcodesindogsaffectedbymitralvalvediseasewithandwithoutpulmonaryhypertensionusingmalditofmsandlcmsms |